Prosecution Insights
Prosecution Insights
24 pending office actions • 6 art units • 17 examiners • 0 of 24 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 9 (38%) |
| §102 only | 2 (8%) |
| §112 only | 4 (17%) |
| No statute on record | 9 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POLIAKOVA-GEORGAN, EKATERINA | 4 | 64.6% | +17.0% |
| VYAS, KEYUR ANILKUMAR | 3 | 51.5% | +63.5% |
| SHUKLA, RAM R | 2 | 15.4% | -1.8% |
| PERSONS, JENNA L | 2 | 52.8% | +65.0% |
| BEANE, RANDALL L | 1 | 32.5% | +37.8% |
| KRISHNAN, GANAPATHY | 1 | 52.2% | +0.0% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.7% |
| TATGE, LEXUS MARC | 1 | — | — |
| KONOPKA, CATHERINE ANNE | 1 | 58.8% | +63.7% |
| SHIN, DANA H | 1 | 27.2% | +27.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17481679 | COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION | SHUKLA, RAM R | 532d overdue |
| 18158290 | COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION | SHUKLA, RAM R | 58d overdue |
| 18001241 | COMPOUNDS AND METHODS FOR REDUCING MSH3 EXPRESSION | SHIN, DANA H | 30d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18443619 | COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION | VYAS, KEYUR ANILKUMAR | 282d overdue |
| 18150395 | ANTISENSE COMPOUNDS | VYAS, KEYUR ANILKUMAR | 247d overdue |
| 17424672 | COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION | PERSONS, JENNA L | 66d overdue |
| 17802324 | COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 51d overdue |
| 18001241 | COMPOUNDS AND METHODS FOR REDUCING MSH3 EXPRESSION | SHIN, DANA H | 30d overdue |
| 18546462 | COMPOUNDS AND METHODS FOR REDUCING NLRP3 EXPRESSION | CHONG, KIMBERLY | 24d overdue |
| 18585339 | GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | BEANE, RANDALL L | 15d overdue |
| 17372173 | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS | POLIAKOVA-GEORGAN, EKATERINA | 10d overdue |
| Art Unit | Apps |
|---|---|
| 1637 | 13 |
| 1635 | 6 |
| 1636 | 2 |
| 1654 | 1 |
| 1693 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18585339 | GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | BEANE, RANDALL L | 1654 | §103 | Final Rejection | 15d overdue | Pending | Feb 23, 2024 |
| 18443619 | COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Non-Final OA | 282d overdue | Pending | Feb 16, 2024 |
| 18548711 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | KRISHNAN, GANAPATHY | 1693 | §103 | Non-Final OA | 8d | Pending | Sep 01, 2023 |
| 18546462 | COMPOUNDS AND METHODS FOR REDUCING NLRP3 EXPRESSION | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | 24d overdue | Pending | Aug 15, 2023 |
| 18263194 | COMPOUNDS AND METHODS FOR MODULATING HUNTINGTIN | TATGE, LEXUS MARC | 1637 | §103 | Non-Final OA | 13d | Pending | Jul 27, 2023 |
| 18262438 | COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION | KONOPKA, CATHERINE ANNE | 1635 | Other | Non-Final OA | 8d overdue | Pending | Jul 21, 2023 |
| 18247567 | METHODS FOR REDUCING APOCIII EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Other | Non-Final OA | 4d overdue | Pending | Mar 31, 2023 |
| 18158290 | COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION | SHUKLA, RAM R | 1635 | Other | Non-Final OA | 58d overdue | Pending | Jan 23, 2023 |
| 18150395 | ANTISENSE COMPOUNDS | VYAS, KEYUR ANILKUMAR | 1637 | Other | Non-Final OA | 247d overdue | Pending | Jan 05, 2023 |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103 | Non-Final OA | 3d overdue | Pending | Dec 14, 2022 |
| 18001241 | COMPOUNDS AND METHODS FOR REDUCING MSH3 EXPRESSION | SHIN, DANA H | 1635 | §102 | Non-Final OA | 30d overdue | Pending | Dec 08, 2022 |
| 17998141 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | ROSSI, JULIA ANNE LORRAIN | 1615 | §103 | Non-Final OA | 67d overdue | Pending | Nov 07, 2022 |
| 17802324 | COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103 | Non-Final OA | 51d overdue | Pending | Aug 25, 2022 |
| 17721765 | Compositions for Modulating C9ORF72 Expression | PERSONS, JENNA L | 1637 | Other | Final Rejection | 9d overdue | Pending | Apr 15, 2022 |
| 17611780 | ANGIOTENSIN II TYPE 1 RECEPTOR TARGETED OLIGONUCLEOTIDES AND USES THEREOF | ARIETI, RUTH SOPHIA | 1635 | Other | Final Rejection | 60d overdue | Pending | Nov 16, 2021 |
| 17522594 | COMPOUNDS AND METHODS FOR REDUCING SNCA EXPRESSION | MCLEOD, AFRICA MHAIRIE | 1635 | §112 | Non-Final OA | 86d overdue | Pending | Nov 09, 2021 |
| 17481679 | COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION | SHUKLA, RAM R | 1635 | §102 | Non-Final OA | 532d overdue | Pending | Sep 22, 2021 |
| 17432237 | COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Final Rejection | 71d overdue | Pending | Aug 19, 2021 |
| 17424672 | COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION | PERSONS, JENNA L | 1637 | Other | Final Rejection | 66d overdue | Pending | Jul 21, 2021 |
| 17372173 | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103 | Final Rejection | 10d overdue | Pending | Jul 09, 2021 |
| 17365307 | OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE | TRAN, CHRISTINA L | 1637 | Other | Final Rejection | 86d overdue | Pending | Jul 01, 2021 |
| 17416108 | MODULATORS OF HSD17B13 EXPRESSION | ANGELL, JON E | 1637 | §112 | Final Rejection | 4d overdue | Pending | Jun 18, 2021 |
| 17291199 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS | QIAN, CELINE X | 1637 | §112 | Non-Final OA | 4d overdue | Pending | May 04, 2021 |
| 16951449 | Compounds and Methods for Modulation of Transcript Processing | VYAS, KEYUR ANILKUMAR | 1637 | Other | Final Rejection | 2d overdue | Pending | Nov 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial